File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Era of direct acting antivirals in chronic hepatitis C: Who will benefit?

TitleEra of direct acting antivirals in chronic hepatitis C: Who will benefit?
Authors
Fung, JYY
KeywordsBenefit
Chronic hepatitis C
Cirrhosis
Direct acting antivirals
Liver transplantation
Treatment
Unmet needs
Issue Date2015
Citation
World Journal of Hepatology, 2015, v. 7 n. 24, p. 2543-2550 How to Cite?
DOI: http://dx.doi.org/10.4254/wjh.v7.i24.2543
Persistent Identifierhttp://hdl.handle.net/10722/224888
ISSN
1948-5182
2023 Impact Factor: 2.5
2023 SCImago Journal Rankings: 0.673
ISI Accession Number ID
WOS:000439212700006

 

DC FieldValueLanguage
dc.contributor.authorFung, JYY-
dc.date.accessioned2016-04-18T03:33:48Z-
dc.date.available2016-04-18T03:33:48Z-
dc.date.issued2015-
dc.identifier.citationWorld Journal of Hepatology, 2015, v. 7 n. 24, p. 2543-2550-
dc.identifier.issn1948-5182-
dc.identifier.urihttp://hdl.handle.net/10722/224888-
dc.languageeng-
dc.relation.ispartofWorld Journal of Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectBenefit-
dc.subjectChronic hepatitis C-
dc.subjectCirrhosis-
dc.subjectDirect acting antivirals-
dc.subjectLiver transplantation-
dc.subjectTreatment-
dc.subjectUnmet needs-
dc.titleEra of direct acting antivirals in chronic hepatitis C: Who will benefit?-
dc.typeArticle-
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hk-
dc.identifier.authorityFung, JYY=rp00518-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.4254/wjh.v7.i24.2543-
dc.identifier.scopuseid_2-s2.0-84945957192-
dc.identifier.hkuros257546-
dc.identifier.volume7-
dc.identifier.spage2543-
dc.identifier.epage2550-
dc.identifier.isiWOS:000439212700006-
dc.identifier.issnl1948-5182-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats